Victor Thijssen

Victor Thijssen

Vrije Universiteit Amsterdam

H-index: 46

Europe-Netherlands

About Victor Thijssen

Victor Thijssen, With an exceptional h-index of 46 and a recent h-index of 29 (since 2020), a distinguished researcher at Vrije Universiteit Amsterdam, specializes in the field of Oncology, Angiogenesis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations

Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol

Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy

Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives

Examination of the Role of Galectins and Galectin Inhibitors in Endothelial Cell Biology

Galectokines: the promiscuous relationship between galectins and cytokines

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)

C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration

Victor Thijssen Information

University

Position

Associate Professor, VU University medical center

Citations(all)

7074

Citations(since 2020)

2684

Cited By

5398

hIndex(all)

46

hIndex(since 2020)

29

i10Index(all)

79

i10Index(since 2020)

66

Email

University Profile Page

Vrije Universiteit Amsterdam

Google Scholar

View Google Scholar Profile

Victor Thijssen Skills & Research Interests

Oncology

Angiogenesis

Top articles of Victor Thijssen

Title

Journal

Author(s)

Publication Date

Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations

Frontiers in Immunology

Tessa S Groen-van Schooten

Micaela Harrasser

Jens Seidel

Emma N Bos

Tania Fleitas

...

2024/4/4

Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol

BMC cancer

Yasmin A Civil

Arlene L Oei

Katya M Duvivier

Nina Bijker

Philip Meijnen

...

2023/5/9

Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy

Angiogenesis

Patrycja Nowak-Sliwinska

Judy R van Beijnum

Christian J Griffioen

Zowi R Huinen

Nadine Grima Sopesens

...

2023/5

Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives

Tesfay M Godefa

Sarah Derks

Victor LJL Thijssen

2022/11/24

Examination of the Role of Galectins and Galectin Inhibitors in Endothelial Cell Biology

Kitty CM Castricum

Victor LJL Thijssen

2022/3/24

Galectokines: the promiscuous relationship between galectins and cytokines

Lucía Sanjurjo

Esmee C Broekhuizen

Rory R Koenen

Victor LJL Thijssen

2022/9/13

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)

Therapeutic advances in medical oncology

Charlotte I Stroes

Sandor Schokker

Mohammed Khurshed

Stephanie O van der Woude

Ron AA Mathôt

...

2022/6

C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration

Cells

Leonie Hartl

Pien AF Maarschalkerweerd

Joe M Butler

Xue D Manz

Victor LJL Thijssen

...

2022/10/22

Metallated phthalocyanines and their hydrophilic derivatives for multi-targeted oncological photodynamic therapy

Journal of Photochemistry and Photobiology B: Biology

Lionel Mendes Dias

Mark J de Keijzer

Daniël Ernst

Farangis Sharifi

Daniel J de Klerk

...

2022/9/1

Method to Study the Role of Galectins in Angiogenesis In Vivo Using the Chick Chorioallantoic Membrane Assay

Kitty CM Castricum

Victor LJL Thijssen

2022/3/24

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden

Cancer Immunology, Immunotherapy

Julia Femel

Luuk van Hooren

Melanie Herre

Jessica Cedervall

Falk Saupe

...

2022/10

Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden

Cancer Immunology, Immunotherapy

Julia Femel

Luuk van Hooren

Melanie Herre

Jessica Cedervall

Falk Saupe

...

2022/8

Galectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro

PLoS One

Annemiek Dickhout

Bibian ME Tullemans

Johan WM Heemskerk

Victor LJL Thijssen

Marijke JE Kuijpers

...

2021/1/7

Interferon-and STING-independent induction of type I interferon stimulated genes during fractionated irradiation

Journal of Experimental & Clinical Cancer Research

Ruben SA Goedegebuure

Esther A Kleibeuker

Francesca M Buffa

Kitty CM Castricum

Syed Haider

...

2021/5/8

Chemokines modulate glycan binding and the immunoregulatory activity of galectins

Communications Biology

Lucía Sanjurjo

Iris A Schulkens

Pauline Touarin

Roy Heusschen

Ed Aanhane

...

2021/12/20

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies

Molecular oncology

Leonie K de Klerk

Ruben SA Goedegebuure

Nicole CT van Grieken

Johanna W van Sandick

Annemieke Cats

...

2021/4

Galectins in endothelial cell biology and angiogenesis: The basics

Victor L Thijssen

2021/9/20

Development of transient radioresistance during fractionated irradiation in vitro

Radiotherapy and Oncology

Jaap van den Berg

Kitty CM Castricum

Michaël H Meel

Ruben SA Goedegebuure

Frank J Lagerwaard

...

2020/7/1

Combining radiation therapy with interferons: back to the future

Ruben SA Goedegebuure

Christian Vonk

Laura P Kooij

Sarah Derks

Victor LJL Thijssen

2020/9/1

See List of Professors in Victor Thijssen University(Vrije Universiteit Amsterdam)